Back to search

Aristotle University Of Thessaloniki (AUTH)

Investigation of the role of specific IgE and total IgE in patients with atopy, allergy, chronic obstructive pulmonary disease and asthma

Abstract

dc:description

Introduction: Immunoglobulin E (IgE) plays a central role in allergic responses, and allergic diseases often involve IgE production by plasma cells upon exposure to harmless antigens. Hypersensitivity reactions are exaggerated immune responses to antigens and are classified into Types I-IV. Specific skin diseases exhibit various hypersensitivity reactions. Atopic dermatitis is a Type I response involving IgE-mediated inflammation and skin barrier disruption. Pemphigus vulgaris is a Type II disease characterized by autoantibodies against keratinocyte proteins, leading to blistering. Bullous pemphigoid, another Type II disease, involves autoantibodies against hemidesmosomal proteins, causing blistering and inflammation. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis represent Type IV reactions with severe skin detachment, often drug-induced. Drug reaction with eosinophilia and systemic symptoms (DRESS) is a Type IV response characterized by widespread rash, visceral organ involvement, eosinophilia, and lymphadenopathy. Contact dermatitis, a common Type IV response, arises from exposure to allergens or irritants, often requiring patch testing for diagnosis. COPD and asthma are among the leading causes of chronic morbidity and mortality throughout the world. Total (tIgE) and allergen-specific IgE (sIgE) levels have been associated with asthma in many previous studies. Recent data support the importance of IgE-sensitization to COPD onset and severity. Sensitization to Staphylococcus aureus enterotoxins A (SEA) and B (SEB) has been associated with asthma severity, exacerbations, and disease control. Aims: This doctoral thesis aimed to investigate the role of hypersensitivity in important diseases of the skin and the lung and to elucidate whether there are differences in serum tIgE and sIgE profile between patients with COPD, asthma, atopy, allergy and controls. These serum biomarkers were further associated with disease pathogenesis, severity, outcome and infectious history in a well characterized group of >400 patients. Materials and Methods: The study comprises two arms. The first arm, includes a case-control study with 76 COPD patients [of whom 16 (21.05%) were atopic], 19 asthma patients and 27 controls and aims to determine the possible association of tIgE and sIgE (exposure factors) with disease incidence (asthma and COPD). To further extend the study, the results that were obtained in the first arm were validated in a second arm including a larger group of COPD patients [N= 343, including 113 (32.94%) patients with atopy and 81 (23.96%) patients with allergy]. Serum samples from patients were analyzed for tIgE and sIgE levels using the ALEX2 Allergy Explorer, an immunoassay test based on ELISA. Additionally, serum specific SEA-IgE and SEB-IgE were measured using the ImmnoCAP assay. Patients were considered atopic when tIgE ≥ 100 kUA/L and allergic when their skin prick test was positive. Results: Although the frequency of SEA and SEB sensitization does not appear higher in COPD patients compared to asthma patients and controls, atopy and allergy are linked to SEA-IgE and SEB-IgE positivity in COPD patients. Asthma, COPD, and control groups showed no significant differences in total IgE levels, but asthmatic patients exhibit higher sIgE concentrations for aeroallergens, seasonal aeroallergens, and food allergens, while controls have higher non-aeroallergen sIgE concentrations. Asthma and COPD patients show distinct sIgE concentration patterns for various allergens. There is an inverse association of atopy with acute exacerbations of COPD (AECOPD), especially in male patients, while allergy has a positive association with AECOPD, particularly in female COPD patients. The etiological type of AECOPD (viral, bacterial, or concomitant) appears unrelated to atopic and allergic profiles. Atopy and allergy also impact lung function and symptom severity in COPD. Certain allergens correlate with worsened FEV1%, while others positively affect FEV1% values. Non-allergic COPD patients display higher lung diffusion capacity, and atopy enhances 6-minute walking test (6MWT) distance and Modified Medical Research Council Dyspnea Scale (MMRC) scores. Elevated sIgE concentrations for perineal aeroallergens are associated with more severe COPD, and high tIgE levels are linked to greater airflow limitation. Atopy influences the presence of symptoms, such as cough and shortness of breath. Furthermore, allergic COPD patients show lower smoking history, and specific allergens correlate negatively with fractional exhaled nitric oxide (FeNO) levels. Blood eosinophil counts are higher in allergic subjects, while atopy does not significantly associate with eosinophil levels. Infections, including Haemophilus influenzae in sputum, are linked to allergy and atopy. Fungal sensitization associates with specific clinical characteristics, such as lower oxygen saturation during the 6MWT, in older COPD patients. Patients who are both atopic and allergic show elevated sensitization and IgE levels compared to those with either trait alone, without significant differences in demographic or clinical factors. Conclusions: Understanding hypersensitivity reactions and their associated skin diseases is crucial for accurate diagnosis and effective pharmacological treatment of patients. This study sheds light on the intricate relationships between sensitization, clinical parameters, and biomarkers in COPD patients. In other words, determining the allergic and atopic profile of COPD patients can assist clinicians in identifying subgroups with more severe disease, worse lung function, or a poorer prognosis. This information can guide the development of early management strategies and pharmacotherapy.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karakioulaki, Meropi
  • Καρακιουλάκη, Μερόπη

Subjects

dc:subject × 16

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55185

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karakioulaki, Meropi; Καρακιουλάκη, Μερόπη. Investigation of the role of specific IgE and total IgE in patients with atopy, allergy, chronic obstructive pulmonary disease and asthma. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/55185